James Loerop
2021
In 2021, James Loerop earned a total compensation of $874.4K as EVP, Business Development and Strategic Planning at Anika Therapeutics, a 16% decrease compared to previous year.
Compensation breakdown
| Option Awards | $228,138 |
|---|---|
| Salary | $394,900 |
| Stock Awards | $227,970 |
| Other | $23,396 |
| Total | $874,404 |
Loerop received $394.9K in salary, accounting for 45% of the total pay in 2021.
Loerop also received $228.1K in option awards, $228K in stock awards and $23.4K in other compensation.
Rankings
In 2021, James Loerop's compensation ranked 9,205th out of 12,404 executives tracked by ExecPay. In other words, Loerop earned more than 25.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,205 out of 12,404 | 26th |
Division Manufacturing | 4,083 out of 5,494 | 26th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 540 out of 798 | 32nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 343 out of 519 | 34th |
Industry Surgical and Medical Instruments and Apparatus | 218 out of 324 | 33rd |
Source: SEC filing on April 27, 2022.
Loerop's colleagues
We found four more compensation records of executives who worked with James Loerop at Anika Therapeutics in 2021.